Monday, 24 February 2020

Vaccines News

  • EU reviews Sanofi's 4-in-1 Influenza vaccine

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 12 Apr, 2013

    Singapore: Sanofi Pasteur has been accepted for review in the European Union for a quadrivalent (four-strain) formulation of Vaxigrip. The file has been accepted for review by France's Agen...Read more

  • Admedus increases share in Ian Frazer vaccine tech

    Vaccines |  News | By BioSpectrum Bureau  | 2 Comment | 24 Jul, 2014

    Singapore: Australia's healthcare company focused on investing in and developing next generation technologies, Admedus, has increased its ownership in Admedus Vaccines, the platform vaccine...Read more

  • Are declining Ebola cases a challenge for clinical studies?

    Vaccines |  Analysis | By BioSpectrum Bureau  | 0 Comment | 16 Mar, 2015

    Singapore: The steady decline in new ebola cases presents a formidable challenge to current and future clinical trials of investigational treatments for the disease, as it will be more diff...Read more

  • BMS releases $3.5 mn fund for Hep B&C in India, China

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 04 Dec, 2014

    Singapore: Bristol-Myers-Squibb Foundation has released nine new grants totaling to around $3.5 million towards hepatitis B virus (HBV) and hepatitis C virus (HCV) in India and China. The ...Read more

  • SII seeks WHO consent to export flu vaccines

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 12 Dec, 2012

    Singapore: Serum Institute of India (SII) has applied for permits to export flu vaccines produced using Australia's BioDiem's proprietary technology. The permit is applied with the World H...Read more

  • Vaccine must to curb AIDS

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 23 Feb, 2015

    Singapore: In a recent conference organized by the International AIDS Vaccine Institute, experts said that though the world has made considerable progress in curbing AIDS it was important t...Read more

  • Italy clears Novartis seasonal influenza vaccines

    Vaccines |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 14 Nov, 2012

    Singapore: The Italian Medicines Agency (AIFA) has lifted the temporary halt on the use of Agrippal and Fluad vaccines in Italy. The decision follows additional information provided by the ...Read more

  • Bridge to the DNA vaccine dream

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jun, 2012

    Can DNA vaccines be the answer to diseases such as malaria and influenza? Though DNA-based vaccines have emerged as appealing alternatives to conventional ones, there are still gaps to be f...Read more

  • Vaccine delivery technologies of the future

    Vaccines |  Analysis | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2012

    Respiratory syncytial virus (RSV), a disease that causes infections of the lower respiratory tract mostly in infants and children, claims lives of nearly 200,000 children every year. Nearly...Read more

  • Polio vac mandatory for travelers from 7 nations: India

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 05 Mar, 2014

    Singapore: All travelers coming from these countries to India would need to take OPV six weeks before departure from their country. Polio vaccine will also be administered to all travelers ...Read more

  • New malaria vaccine produced from algae

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 19 Feb, 2015

    Singapore: US researchers have developed a new candidate vaccine for malaria from algae. In a study, published in the journal Infection and Immunity, scientists elaborated that paired with ...Read more

  • No vaccination, No benefits, says Australian PM

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 21 Apr, 2015

    Singapore: Australian government has recently made an announcement that parents who refuse to vaccinate their children may lose up to AUD$11,000 worth welfare benefits a year. The new polic...Read more

  • The unconventional side of vaccines

    Vaccines |  Opinion | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2012

    When we talk about vaccines, most people think of an injection to prevent childhood infectious disease. However, in recent years the uses to which vaccines are being put has expanded dramat...Read more

  • Singaporean travelers highly prone to Hepatitis A

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 30 Oct, 2012

    Singapore: A study conducted in Singapore has revealed that people, who travel to high risk areas associated with infectious diseases, are increasingly getting infected by the Hepatitis A ...Read more

  • IAVI vaccine design can eliminate HIV

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 02 Apr, 2013

    Singapore: A team led by scientists from the Scripps Research Institute (TSRI) and the International AIDS Vaccine Initiative (IAVI) has unveiled a new technique for vaccine design that coul...Read more

  • Pfizer wins the race

    Vaccines |  Analysis | By Aishwarya Venkatesh  | 0 Comment | 31 Oct, 2014

    Singapore: The toe-to-toe battle between Pfizer and Novartis is not new to the pharma industry. The drug giants were racing to win the federal approval to first market their meningitis B va...Read more

  • Fujifilm to acquire US-based vaccine maker

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 31 Oct, 2014

    Singapore: Japan's Fujifilm has inked a deal to acquire US-based Kalon Bio therapeutics, which has expertise in manufacturing vaccines used against pandemic influenza, Ebola and other publi...Read more

  • Abivax initiates hepB vaccine trial in Asia

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 03 Mar, 2015

    Singapore: ABIVAX, a clinical stage biotech company developing and commercialising anti-viral compounds and human vaccines, has initiated Phase IIb/III clinical trial of drug candidate ABX2...Read more